Registration Rights Agreements in the Biotechnology Industry
1,182 Contracts & Agreements
- 2seventy bio, Inc. (1 contract)
- AbbVie Inc. (1)
- ABEONA THERAPEUTICS INC. (2)
- ACADIA PHARMACEUTICALS INC (2)
- ACCELERON PHARMA INC (1)
- ACHIEVE LIFE SCIENCES, INC. (4)
- Acorda Therapeutics (3)
- Actinium Pharmaceuticals, Inc. (3)
- Adhera Therapeutics, Inc. (3)
- ADiTx Therapeutics, Inc. (7)
- ADMA BIOLOGICS, INC. (2)
- Advaxis, Inc. (11)
- Adverum Biotechnologies, Inc. (1)
- Aeglea BioTherapeutics, Inc. (8)
- AGENUS INC (1)
- AgeX Therapeutics, Inc. (5)
- AILERON THERAPEUTICS INC (3)
- Aimmune Therapeutics, Inc. (3)
- Akebia Therapeutics, Inc. (1)
- ALBIREO PHARMA, INC. (2)
- Aldeyra Therapeutics, Inc. (2)
- Alector, Inc. (1)
- Alexion Pharmaceuticals (1)
- Allarity Therapeutics, Inc. (4)
- Allena Pharmaceuticals, Inc. (1)
- Alliqua BioMedical, Inc. (5)
- Alpha Healthcare Acquisition Corp. (2)
- ALPINE IMMUNE SCIENCES, INC. (3)
- Altimmune, Inc. (2)
- AMARILLO BIOSCIENCES INC (2)
- Amgen Inc. (2)
- AmpliPhi Biosciences Corp (8)
- Amplitude Healthcare Acquisition Corp (3)
- ANAVEX LIFE SCIENCES CORP. (7)
- Anika Therapeutics (1)
- Annovis Bio, Inc. (1)
- Applied Therapeutics Inc. (3)
- Aprea Therapeutics, Inc. (3)
- Aptevo Therapeutics Inc. (5)
- Aptose Biosciences Inc. (2)
- AQUINOX PHARMACEUTICALS, INC (2)
- Aravive, Inc. (2)
- ARCA biopharma, Inc. (6)
- Arcturus Therapeutics Holdings Inc. (1)
- Arcutis Biotherapeutics, Inc. (1)
- ARDELYX, INC. (1)
- ARENA PHARMACEUTICALS INC (4)
- ARROWHEAD PHARMACEUTICALS, INC. (7)
- Arsanis, Inc. (7)
- ARYA Sciences Acquisition Corp II (3)
- Athenex, Inc. (4)
- ATHERSYS, INC (8)
- ATOSSA GENETICS INC (6)
- Atreca, Inc. (1)
- aTYR PHARMA INC (3)
- AVEO PHARMACEUTICALS INC (4)
- Avid Bioservices, Inc. (3)
- Avidity Biosciences, Inc. (1)
- AZIYO BIOLOGICS, INC. (2)
- AzurRx BioPharma, Inc. (5)
- BCTG Acquisition Corp. (1)
- BeiGene, Ltd. (3)
- BELLICUM PHARMACEUTICALS, INC (1)
- BICYCLE THERAPEUTICS Ltd (1)
- Big Cypress Acquisition Corp. (3)
- BIO-PATH HOLDINGS INC (1)
- BioCardia, Inc. (4)
- BIOCEPT INC (1)
- BIOCRYST PHARMACEUTICALS INC (1)
- Biohaven Pharmaceutical Holding Co Ltd. (1)
- BIOMARIN PHARMACEUTICAL INC (1)
- BIOSPECIFICS TECHNOLOGIES CORP (1)
- Biostage, Inc. (1)
- BIOTIME INC (3)
- BIOVIE INC. (3)
- BioXcel Therapeutics, Inc. (1)
- BIOXYTRAN, INC (2)
- Bison Capital Acquisition Corp. (4)
- Blue Water Vaccines Inc. (2)
- bluebird bio, Inc. (2)
- Bone Biologics Corp (3)
- BRAINSTORM CELL THERAPEUTICS INC. (1)
- BridgeBio Pharma, Inc. (4)
- CALADRIUS BIOSCIENCES, INC. (10)
- Calyxt, Inc. (1)
- CANCER GENETICS, INC (6)
- CAPRICOR THERAPEUTICS, INC. (4)
- CAPSTAR SPECIAL PURPOSE ACQUISITION CORP. (3)
- Capstone Therapeutics Corp. (2)
- CareDx, Inc. (3)
- CATABASIS PHARMACEUTICALS INC (2)
- CATALYST PHARMACEUTICALS, INC. (1)
- Celcuity Inc. (2)
- Cell Source, Inc. (1)
- Cellectar Biosciences, Inc. (8)
- Cellular Biomedicine Group, Inc. (2)
- Celsion CORP (7)
- Centessa Pharmaceuticals Ltd (2)
- Chanticleer Holdings, Inc. (3)
- Chardan Healthcare Acquisition 2 Corp. (3)
- Chardan Healthcare Acquisition Corp. (5)
- Chelsea Worldwide Inc. (1)
- Cibus Global, Ltd. (1)
- CLEVELAND BIOLABS INC (6)
- Clovis Oncology, Inc. (1)
- CM Life Sciences III Inc. (5)
- Coherus BioSciences, Inc. (3)
- Comera Life Sciences Holdings, Inc. (4)
- Conatus Pharmaceuticals Inc. (4)
- Consonance-HFW Acquisition Corp. (3)
- Constellation Alpha Capital Corp. (5)
- CONSTELLATION PHARMACEUTICALS INC (1)
- CONTRAFECT Corp (1)
- Corbus Pharmaceuticals Holdings, Inc. (1)
- CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (2)
- Crinetics Pharmaceuticals, Inc. (1)
- CRISPR Therapeutics AG (1)
- CTD HOLDINGS INC (2)
- CTI BIOPHARMA CORP (5)
- Cue Biopharma, Inc. (3)
- Cullinan Oncology, LLC (2)
- CURIS INC (5)
- Cyclacel Pharmaceuticals, Inc. (4)
- CytoDyn Inc. (2)
- Cytokinetics, Incorporated (2)
- CytomX Therapeutics, Inc. (1)
- CYTORI THERAPEUTICS, INC. (5)
- CYTRX CORP (3)
- DBV Technologies S.A. (1)
- Deciphera Pharmaceuticals, Inc. (2)
- DelMar Pharmaceuticals, Inc. (1)
- Dermavant Sciences Ltd (1)
- DiaMedica Therapeutics Inc. (2)
- Dicerna Pharmaceuticals Inc (3)
- Diffusion Pharmaceuticals Inc. (3)
- Digital Development Partners, Inc. (1)
- DYADIC INTERNATIONAL INC (1)
- Dynamics Special Purpose Corp. (3)
- Edge Therapeutics, Inc. (1)
- Emerald Bioscience, Inc. (10)
- Emergent BioSolutions Inc. (4)
- Enanta Pharmaceuticals, Inc. (1)
- ENDONOVO THERAPEUTICS, INC. (4)
- Enochian Biosciences Inc (3)
- Entasis Therapeutics Holdings Inc. (7)
- Entera Bio Ltd. (1)
- Environmental Impact Acquisition Corp (2)
- Equillium, Inc. (1)
- Esperion Therapeutics, Inc. (1)
- Evelo Biosciences, Inc. (1)
- EXACT SCIENCES CORP (1)
- Exelixis (5)
- EXICURE, INC. (4)
- FATE THERAPEUTICS INC (2)
- Fibrocell Science, Inc. (7)
- Flex Pharma, Inc. (2)
- FLUOROPHARMA MEDICAL, INC. (8)
- Frequency Therapeutics, Inc. (2)
- FS Development Corp. (3)
- FS Development Corp. II (3)
- Fusion Pharmaceuticals Inc. (3)
- G1 Therapeutics, Inc. (1)
- GALECTIN THERAPEUTICS INC (8)
- Gamida Cell Ltd. (1)
- Gemphire Therapeutics Inc. (3)
- GENEREX BIOTECHNOLOGY CORP (16)
- GENOCEA BIOSCIENCES, INC. (2)
- Genprex, Inc. (1)
- GeoVax Labs, Inc. (6)
- Gilead Sciences (1)
- Graphite Bio, Inc. (1)
- Greater Cannabis Company, Inc. (1)
- Greenwich LifeSciences, Inc. (1)
- GT Biopharma, Inc. (8)
- GTX INC (2)
- GX Acquisition Corp. (7)
- HARBOR DIVERSIFIED, INC. (2)
- Harpoon Therapeutics, Inc. (2)
- Health Sciences Acquisitions Corp (3)
- HEAT BIOLOGICS, INC. (3)
- HedgePath Pharmaceuticals, Inc. (2)
- HEMISPHERX BIOPHARMA INC (1)
- HERON THERAPEUTICS, INC. (2)
- HISTOGENICS CORP (2)
- Homology Medicines, Inc. (1)
- HOOKIPA Pharma Inc. (1)
- HUMANIGEN, INC (4)
- iBio, Inc. (5)
- IDERA PHARMACEUTICALS, INC. (12)
- IGM Biosciences, Inc. (1)
- IMMUCELL CORP (1)
- IMMUNE PHARMACEUTICALS INC (3)
- ImmunoCellular Therapeutics, Ltd. (5)
- IN8BIO, INC. (1)
- Incyte (2)
- Inhibikase Therapeutics, Inc. (1)
- InMed Pharmaceuticals Inc. (6)
- Inmune Bio, Inc. (2)
- Innovation Pharmaceuticals Inc. (4)
- INOVIO PHARMACEUTICALS, INC. (4)
- Inozyme Pharma, Inc. (1)
- INSMED Inc (2)
- Inspyr Therapeutics, Inc. (11)
- Intec Parent Inc. (2)
- Intec Pharma Ltd. (1)
- International Stem Cell CORP (4)
- INTREXON CORP (1)
- Intrinsic Medicine, Inc. (1)
- Invitae Corp (17)
- IO Biotech, Inc. (1)
- IOVANCE BIOTHERAPEUTICS, INC. (3)
- Isoray, Inc. (4)
- Jounce Therapeutics, Inc. (1)
- Kadmon Holdings, Inc. (5)
- KalVista Pharmaceuticals, Inc. (3)
- Karyopharm Therapeutics Inc. (1)
- KBL MERGER CORP. IV (7)
- Kindred Biosciences, Inc. (1)
- Kodiak Sciences Inc. (1)
- Krystal Biotech, Inc. (1)
- Kura Oncology, Inc. (2)
- Kymera Therapeutics, Inc. (1)
- LEAP THERAPEUTICS, INC. (4)
- Leisure Acquisition Corp. (6)
- LEXICON PHARMACEUTICALS, INC. (2)
- LifeSci Acquisition Corp. (3)
- Locust Walk Acquisition Corp. (5)
- LONGEVERON LLC (1)
- MACROGENICS INC (2)
- MADRIGAL PHARMACEUTICALS, INC. (1)
- Magenta Therapeutics, Inc. (2)
- MANNKIND CORP (1)
- MARIZYME INC (8)
- Marker Therapeutics, Inc. (5)
- MATEON THERAPEUTICS INC (13)
- Matinas BioPharma Holdings, Inc. (1)
- MEDICINOVA INC (3)
- Medovex Corp. (3)
- MEI Pharma, Inc. (10)
- MeiraGTx Holdings plc (2)
- Millendo Therapeutics, Inc. (4)
- MiMedx Group, Inc. (4)
- Minerva Neurosciences, Inc. (2)
- MIRAGEN THERAPEUTICS, INC. (4)
- Mirum Pharmaceuticals, Inc. (1)
- Molecular Templates, Inc. (2)
- Moleculin Biotech, Inc. (3)
- Momenta Pharmaceuticals, Inc. (1)
- Monopar Therapeutics (5)
- Morphic Holding, Inc. (1)
- NANOVIRICIDES, INC. (1)
- NantKwest, Inc. (4)
- NAVIDEA BIOPHARMACEUTICALS, INC. (12)
- NEUROCRINE BIOSCIENCES INC (1)
- NEUROTROPE BIOSCIENCE, INC. (3)
- Neurotrope, Inc. (3)
- NORTHWEST BIOTHERAPEUTICS INC (1)
- NOVAVAX INC (2)
- Novus Therapeutics, Inc. (1)
- NTN BUZZTIME INC (10)
- Nuo Therapeutics, Inc. (7)
- NUTRA PHARMA CORP (1)
- Nuvectis Pharma, Inc. (1)
- Ohr Pharmaceutical Inc (3)
- Olivia Ventures, Inc. (2)
- OncBioMune Pharmaceuticals, Inc (3)
- ONCOSEC MEDICAL Inc (6)
- OPGEN INC (2)
- ORAGENICS INC (3)
- Organicell Regenerative Medicine, Inc. (1)
- Organogenesis Holdings Inc. (3)
- ORGANOVO HOLDINGS, INC. (1)
- Orgenesis Inc. (5)
- Outlook Therapeutics, Inc. (4)
- PALATIN TECHNOLOGIES INC (3)
- Pasithea Therapeutics Corp. (1)
- PDL BIOPHARMA, INC. (2)
- Petra Acquisition Inc. (6)
- PharmaCyte Biotech, Inc. (3)
- Phio Pharmaceuticals Corp. (4)
- PIERIS PHARMACEUTICALS, INC. (3)
- POLARITYTE, INC. (9)
- Poseida Therapeutics, Inc. (1)
- PRECISION BIOSCIENCES INC (1)
- Prelude Therapeutics Inc (2)
- PREMIER BIOMEDICAL INC (9)
- PROGENITY, INC. (2)
- ProMIS Neurosciences Inc. (3)
- Propanc Biopharma, Inc. (11)
- Protagenic Therapeutics, Inc. (2)
- Protagonist Therapeutics, Inc (1)
- PROTEON THERAPEUTICS INC (3)
- PROTEOSTASIS THERAPEUTICS, INC. (5)
- PUMA BIOTECHNOLOGY, INC. (3)
- Pyxis Oncology, Inc. (1)
- Q BioMed Inc. (4)
- Rallybio Corp (2)
- RAPT Therapeutics, Inc. (1)
- RECURSION PHARMACEUTICALS, INC. (2)
- Regeneron Pharmaceuticals (1)
- REGENERX BIOPHARMACEUTICALS INC (4)
- Relay Therapeutics, Inc. (1)
- RenovaCare, Inc. (3)
- Repare Therapeutics Inc. (1)
- Retrophin, Inc. (3)
- REXAHN PHARMACEUTICALS, INC. (5)
- Rezolute, Inc. (5)
- Rich Pharmaceuticals, Inc. (2)
- RITTER PHARMACEUTICALS INC (6)
- ROCKET PHARMACEUTICALS, INC. (1)
- Sarepta Therapeutics, Inc. (2)
- Savara Inc (1)
- SEATTLE GENETICS INC (2)
- SELECTA BIOSCIENCES INC (4)
- SELLAS Life Sciences Group, Inc. (5)
- Sensei Biotherapeutics, Inc. (2)
- Sesen Bio, Inc. (3)
- Shattuck Labs, Inc. (1)
- Shuttle Pharmaceuticals Holdings, Inc. (1)
- Social Capital Suvretta Holdings Corp. III (3)
- SOLENO THERAPEUTICS INC (4)
- Solid Biosciences Inc. (5)
- SOLIGENIX, INC. (16)
- SOPHIRIS BIO INC. (3)
- Sorrento Therapeutics, Inc. (12)
- Spectrum Pharmaceuticals, Inc. (5)
- SPHERIX INC (5)
- Spinning Eagle Acquisition Corp. (5)
- Spring Bank Pharmaceuticals, Inc. (2)
- SpringWorks Therapeutics, Inc. (1)
- Summit Therapeutics Inc. (1)
- SUNESIS PHARMACEUTICALS INC (2)
- Sunshine Biopharma, Inc (5)
- SYNLOGIC, INC. (3)
- Synthetic Biologics, Inc. (2)
- Syros Pharmaceuticals, Inc. (4)
- T2 Biosystems, Inc. (3)
- Taysha Gene Therapies, Inc. (1)
- TENAX THERAPEUTICS, INC. (4)
- TG THERAPEUTICS, INC. (3)
- Therapeutics Acquisition Corp. (4)
- Tocagen Inc (1)
- Tonix Pharmaceuticals Holding Corp. (10)
- Tracon Pharmaceuticals, Inc. (2)
- Translate Bio, Inc. (3)
- TREVENA INC (1)
- Trovagene, Inc. (3)
- TScan Therapeutics, Inc. (1)
- Twist Bioscience Corp (2)
- TYME TECHNOLOGIES, INC. (1)
- U.S. Stem Cell, Inc. (10)
- United Therapeutics Corp (1)
- Unity Biotechnology, Inc. (1)
- Unum Therapeutics Inc. (3)
- USA EQUITIES CORP. (2)
- VACCINEX, INC. (10)
- Vaccitech plc (2)
- Vaxart, Inc. (1)
- Vaxxinity, Inc. (2)
- VERACYTE, INC. (2)
- Verastem, Inc. (1)
- Vericel Corp (4)
- Vertex Pharmaceuticals Inc (2)
- VICAL INC (2)
- Vicapsys Life Sciences, Inc. (1)
- Vigil Neuroscience, Inc. (1)
- Viking Therapeutics, Inc. (4)
- VITRO DIAGNOSTICS INC (1)
- vTv Therapeutics Inc. (2)
- WINDTREE THERAPEUTICS INC (10)
- Xenetic Biosciences, Inc. (2)
- Xilio Therapeutics, Inc. (1)
- XOMA Corp (1)
- YIELD10 BIOSCIENCE, INC. (1)
- ZAFGEN, INC. (3)
- ZIOPHARM ONCOLOGY INC (7)
- Zymeworks Inc. (1)
- Registration Rights Agreement, dated March 25, 2024, by and among Q32 Bio Operations Inc. (formerly Q32 Bio Inc.) and certain parties thereto (Homology Medicines, Inc., Filed With SEC on March 27, 2024)
- Registration Rights Agreement, dated March 21, 2024, by and among LENZ Therapeutics, Inc. and certain parties thereto (Graphite Bio, Inc., Filed With SEC on March 22, 2024)
- Second Amended and Restated Registration Rights Agreement, between the Company and the parties thereto, dated March 20, 2024 (BioXcel Therapeutics, Inc., Filed With SEC on March 22, 2024)
- Form of Registration Rights Agreement (Aeglea BioTherapeutics, Inc., Filed With SEC on March 18, 2024)
- Registration Rights Agreement, dated March 13, 2024, between Celularity, Inc. and YA II PN, Ltd (GX Acquisition Corp., Filed With SEC on March 15, 2024)
- Form of Registration Rights Agreement, dated as of March (Emerald Bioscience, Inc., Filed With SEC on March 13, 2024)
- Amendment No. 7 to the Rights Agreement dated as of March 11, 2024 to the Rights Agreement dated March 11, 2018, as amended by Amendment No. 1 thereto, dated as of March 8, 2019,... (HEAT BIOLOGICS, INC., Filed With SEC on March 13, 2024)
- Form of Registration Rights Agreement, dated as of March 11, 2024, by and between Aprea Therapeutics and the purchasers (Aprea Therapeutics, Inc., Filed With SEC on March 12, 2024)
- Form of Registration Rights Agreement, to be dated as of the Closing Date, between the Company and the investor named therein (PROGENITY, INC., Filed With SEC on March 11, 2024)
- Registration Rights Agreement (DYADIC INTERNATIONAL INC, Filed With SEC on March 11, 2024)
- Registration Rights Agreement, dated March 6, 2024 (Isoray, Inc., Filed With SEC on March 6, 2024)
- Form of Registration Rights Agreement, dated as of March 6, 2024, by and among the Company and certain purchasers (Chardan Healthcare Acquisition Corp., Filed With SEC on March 6, 2024)
- Second Amendment to Stockholder Rights Agreement, dated as of March 5, 2024, by and between Sensei Biotherapeutics, Inc. and Equiniti Trust Company, LLC, as rights agent (Sensei Biotherapeutics, Inc., Filed With SEC on March 5, 2024)
- Registration Rights Agreement, dated February 27, 2024, by and among Crinetics Pharmaceuticals, Inc. and the persons party thereto (Crinetics Pharmaceuticals, Inc., Filed With SEC on March 1, 2024)
- Registration Rights Agreement, dated February 27, 2024, by and among the Company and the Purchasers (Applied Therapeutics Inc., Filed With SEC on February 29, 2024)
- Form of Registration Rights Agreement (Pyxis Oncology, Inc., Filed With SEC on February 28, 2024)
- Registration Rights Agreement, dated February 27, 2024, by and among vTv Therapeutics Inc. and the investors party thereto (vTv Therapeutics Inc., Filed With SEC on February 28, 2024)
- Rights Agreement, dated as of February 20, 2024, between Synlogic, Inc. and Equiniti Trust Company LLC, as rights agent (SYNLOGIC, INC., Filed With SEC on February 20, 2024)
- Form of Amended and Restated Registration Rights Agreement by and among Prelude Therapeutics Incorporated and certain Investors (Prelude Therapeutics Inc, Filed With SEC on February 15, 2024)
- Registration Rights Agreement (Unum Therapeutics Inc., Filed With SEC on February 14, 2024)
- Registration Rights Agreement, dated February 13, 2024, by and among Renovaro Inc. and the Sellers (Enochian Biosciences Inc, Filed With SEC on February 14, 2024)
- Form of Securities Purchase and Registration Rights Agreement, dated February 9, 2024, by and among the Company and the Investors (BioCardia, Inc., Filed With SEC on February 9, 2024)
- Registration Rights Agreement by and between the Company and the Investors, dated as of February 7, 2024 (VACCINEX, INC., Filed With SEC on February 7, 2024)
- Form of Registration Rights Agreement (Adverum Biotechnologies, Inc., Filed With SEC on February 5, 2024)
- Registration Rights Agreement, dated as of January 29, 2024, by and among Skye Bioscience, Inc. and the Investors named therein (Emerald Bioscience, Inc., Filed With SEC on January 29, 2024)
- Registration Rights Agreement, dated January 26, 2024, by and among Kura Oncology, Inc. and the persons party thereto (Kura Oncology, Inc., Filed With SEC on January 26, 2024)
- Registration Rights Agreement, by and between the Company and affiliates of Deerfield Management Company, L.P., effective upon January 24, 2024 (WINDTREE THERAPEUTICS INC, Filed With SEC on January 25, 2024)
- Syntone Registration Rights Agreement, dated January 22, 2024 (Outlook Therapeutics, Inc., Filed With SEC on January 24, 2024)
- Form of Registration Rights Agreement (Outlook Therapeutics, Inc., Filed With SEC on January 24, 2024)
- Form of Registration Rights Agreement (Magenta Therapeutics, Inc., Filed With SEC on January 22, 2024)
- Form of Registration Rights Agreement, dated January 8, 2024, by and among the Company and the other parties thereto (Solid Biosciences Inc., Filed With SEC on January 8, 2024)
- Form of Registration Rights Agreement (ADiTx Therapeutics, Inc., Filed With SEC on January 5, 2024)
- First Amendment to Registration Rights Agreement, dated December 27, 2023, by and between Cibus, Inc. and a Cibus Global Majority-in-Interest (Calyxt, Inc., Filed With SEC on December 29, 2023)
- Form of Registration Rights Agreement (TREVENA INC, Filed With SEC on December 28, 2023)
- Registration Rights Agreement, dated December 22, 2023 by and between the Company and the holders signatory thereto (ADiTx Therapeutics, Inc., Filed With SEC on December 26, 2023)
- Registration Rights Agreement, dated as of December 22, 2023, by and among Entera Bio Ltd. and the purchasers party thereto (Entera Bio Ltd., Filed With SEC on December 26, 2023)
- Registration Rights Agreement, dated December 21, 2023, by and between Shattuck Labs, Inc. and the several purchasers signatory thereto (Shattuck Labs, Inc., Filed With SEC on December 22, 2023)
- Form of Registration Rights Agreement, by and among the Company and certain purchasers (June 2023 PIPE) (Aeglea BioTherapeutics, Inc., Filed With SEC on December 22, 2023)
- Form of Registration Rights Agreement (December 2023 PIPE) (Aeglea BioTherapeutics, Inc., Filed With SEC on December 22, 2023)
- Registration Rights Agreement, dated as of December 14, 2023, by and among Eterna Therapeutics Inc. and the parties thereto (NTN BUZZTIME INC, Filed With SEC on December 20, 2023)